JM

Jacob Mauldin

Data Analyst · NYC

Publications

Peer-reviewed research.

Peer-reviewed papers I contributed to across immunology and infectious disease research.

Author line

Direct co-authored papers

Papers where I am listed directly in the author line.

Vaccine. 2026;69:127969

Humoral SARS-CoV-2 vaccine responses are durable in solid organ transplant recipients with and without HIV

Rana MM, Haydel B, Carrara G, Gleason C, Mauldin J, Srivastava K, et al.

Contribution: Biospecimen handling, resources, data curation.

DOI ↗

J Clin Invest. 2023;133(8):e166844

Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants

Changrob S, Halfmann PJ, Liu H, … Mauldin J, Srivastava K, Simon V, Krammer F, … Wilson PC.

Contribution: Biospecimen collection and retrieval.

DOI ↗
Contribution

Study-group contributions

PARIS, PVI, and SeroNet study groups; data collection and analysis, without direct author billing.

Cell Rep Med. 2024;5(3):101474

SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 or XBB.1.5

Abbad A, Yellin T, Singh G, et al.

DOI ↗

Immunity. 2024;57(3):587–599.e4

SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase

Srivastava K, Carreño JM, Gleason C, et al.

DOI ↗

mBio. 2024;15(1):e0225023

Singh G, Abbad A, Kleiner G, et al.

DOI ↗

mBio. 2023;14(6):e0228023

Bhavsar D, Singh G, Sano K, et al.

DOI ↗

EBioMedicine. 2023;98:104886

Aleman A, van Kesteren M, Zajdman AK, et al.

DOI ↗

Lancet Infect Dis. 2023;23(11):1302–1312

Cohn H, Bloom N, Cai GY, et al.

DOI ↗

Nat Commun. 2023;14(1):3235

SARS-CoV-2 variant evolution and onward transmission documented through sequential intrahost sampling

Gonzalez-Reiche AS, Alshammary H, Schaefer S, et al.

DOI ↗